Studies have shown that SGLT2 inhibitors improve hyperglycemia-induced vascular dysfunction by alleviating oxidative stress and inflammation through their glucose-lowering effects, as well as restoring insulin signaling [215]; they also prevent oxidative stress, AGE signaling, and inflammation by inhibiting NADPH oxidase (NOX) [216]. This evidence concerns the gene INS and Hyperglycemia.